HERCULES, Calif.--(BUSINESS WIRE)--Eureka Genomics today announced the closing of a $3.7 million private financing round whose participants included private individuals and undisclosed angel investors. The proceeds will further discovery research aimed at identifying novel microorganisms associated with specific cancers and other important diseases, as well as help grow Eureka Genomics’ high-throughput sequencing and bioinformatics service business on a global basis. Eureka Genomics is an industry leader in the area of advanced bioinformatics analysis associated with next-generation sequencing data, and a provider of high-end services to diagnostics, pharmaceutical/biotechnology, agricultural and cleantech companies, as well as academic, public and private research laboratories.
